Searchable abstracts of presentations at key conferences in endocrinology

ea0056p320 | Clinical case reports - Thyroid/Others | ECE2018

Development of fatal lactic acidosis after inadvertent use of metformin in a non-diabetic hemodialysis patient

Akgur Suat , Oruc Aysegul , Yildiz Abdulmecit , Ersoy Canan , Gullulu Mustafa , Ersoy Alparslan

Metformin is considered to be the first choice in the treatment of type 2 diabetes mellitus. Lactic acidosis is a rare life-threatening complication of metformin with approximately 50% overall mortality. Metformin is contraindicated in patients with factors predisposing to lactic acidosis such as impaired renal function (eGFR <30 mL/min). Herein, we present a hemodialysis patient who developed lactic acidosis after inadvertent usage of metformin.Case...

ea0056p434 | Diabetes complications | ECE2018

Analysis of kidney biopsy findings in diabetic patients

Akgur Suat , Oruc Aysegul , Yildiz Abdulmecit , Ersoy Canan , Aytac Vuruskan Berna , Gullulu Mustafa , Ersoy Alparslan

Kidney disease occurs in diabetic patients during disease course in time. Diabetes duration, co-morbid diseases, presence of retinopathy, family history of diabetic nephropathy (DN) predict kidney involvement. Although DN is the initial diagnosis in diabetics with proteinuria, other diseases like primary glomerulonephritis (GN) could be the reason of kidney involvement. DN is increasing in proportion with the increase in diabetes prevalence, and it has been predicted to contin...

ea0056p848 | Pituitary - Clinical | ECE2018

Tolvaptan usage in hyponatremic patients with syndrome of inappropriate secretion of antidiuretic hormone: a single-center experience

Akgur Suat , Oruc Aysegul , Yildiz Abdulmecit , Ersoy Canan , Gullulu Mustafa , Yavuz Mahmut , Dilek Kamil , Ersoy Alparslan

The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is a disorder of impaired water excretion caused by inability to suppress secretion of antidiuretic hormone. The therapy of SIADH varies with severity of hyponatremia and presence or absence of symptoms. Non-peptide vasopressin receptor antagonists (vaptans) are effective at increasing sodium in euvolemic and hypervolemic states and appear safe. We aimed to evaluate the efficacy of tolvaptan in euvolemic h...